Navigation Links
Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
Date:10/1/2007

physicians an important new disease management option that might reduce the need for further therapeutic intervention after a defined treatment period."

Registration Studies for New Drug Application (NDA)

The clevudine Phase 3 registration program includes two 48-week clinical trials designed to demonstrate the superiority of clevudine 30mg over Hepsera (adefovir dipivoxil) 10mg, each administered once-daily as monotherapy. Clevudine Study 305 will enroll approximately 376 chronic hepatitis B e-antigen positive patients (HBeAg+), and clevudine Study 306 will enroll approximately 480 chronic hepatitis B e-antigen negative patients (HBeAg-). Pharmasset plans to submit the 48-week data from these studies to the FDA as the basis for clevudine marketing approval.

The primary endpoint for the registration studies is a composite endpoint measuring the proportion of patients with both undetectable serum HBV DNA and normalized liver enzyme (ALT) levels following 48 weeks of monotherapy. The registration studies will also assess improvement in liver histology, hepatitis B e-antigen (eAg) seroconversion, decreases in the reservoir of HBV hepatic cccDNA, and quantitative eAg and surface antigen (sAg). The clevudine registration studies will be conducted in the United States, Canada, Brazil, the United Kingdom, Spain, Greece, Turkey, Romania, Czech Republic, Australia, New Zealand, Singapore, Hong Kong and Taiwan. Please see http://www.clinicaltrials.gov or e-mail clinicaltrials@pharmasset.com for more information about the clevudine registration studies.

Assessment of SVR for HBV

After the primary registration data have been obtained at week 48, the Phase 3 studies will continue to week 96 to gather additional safety and efficacy data, as well as to assess clevudine's sustained virologic response (SVR) rate for HBV. SVR is a measure of undet
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmasset Presents Clevudine and Racivir Data at the International HIV Drug Resistance Workshop
2. Pharmasset Announces Clevudine and Hepatitis C Presentations at EASL
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
7. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results Demonstrate Safety and Efficacy at Once-Weekly Dosing
10. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
11. Active Biotechs I-3D Micro-dosing Clinical Trial Concluded
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 Roughly three-quarters ... very confident substituting an interchangeable biosimilar for its ... the same nonproprietary name, according to a survey ... (AMCP,s) Journal of Managed Care & Specialty ... 25 percent of pharmacists would feel as confident ...
(Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is investigating ... ("Vitae" or the "Company") (NASDAQ: VTAE ).  ... Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. ... certain of its officers and/or directors have violated Sections ... 1934.  On February 27, 2015, the ...
(Date:2/27/2015)... 27, 2015 ... sistema di monitoraggio dell,infarto congestizio (CHF - Congestive ...     Vectorious Medical ... sistema per il monitoraggio cardiaco destinato a pazienti ... di aver concluso una raccolta di finanziamenti per ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... of today,s college and university students, the Collegiate Inventors ... a way to implant human liver cells in mice ... composite structural poles have won top honors in this ... and Technology Program received the $15,000 graduate first prize ...
... N.J., Oct. 27 Systech International, innovator of ... in labeling technology, today announced that they are ... at Pack Expo 2010 in Chicago on October ... a first-hand look at an end of packaging ...
Cached Medicine Technology:Winners Announced in 2010 Collegiate Inventors Competition® 2Winners Announced in 2010 Collegiate Inventors Competition® 3Winners Announced in 2010 Collegiate Inventors Competition® 4Winners Announced in 2010 Collegiate Inventors Competition® 5Systech and Marchesini Showcase Complete Serialization Line at Pack Expo 2010 2Systech and Marchesini Showcase Complete Serialization Line at Pack Expo 2010 3
(Date:3/1/2015)... Adults who are not legally married ... or universal policies can now use the QuotesPros.com portal ... insurance companies for single adults can now be researched ... . , The rate plans that nationwide agencies are ... a number of life protection policies. The term, universal ...
(Date:3/1/2015)... New York, New York (PRWEB) March 01, 2015 ... Wright Profemur hip lawsuit (( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled ... that the defense must prepare a witness to ... implant played in the development of the Profemur ... Order filed in U.S. District Court, Northern District ...
(Date:3/1/2015)... The number of transvaginal mesh lawsuits ... few weeks in two New Jersey litigations where attorneys ... Firm announces. , A Case List updated on ... County proceeding established for products manufactured by Johnson & ... earlier, when 90 fewer cases had been centralized. Additionally, ...
(Date:3/1/2015)... ERISAPros is pleased to announce ... the professional staff of its Compliance Department. , Evelyn ... State University-Mortiz College of Law. Prior to joining ERISAPros, ... several Fortune 500 companies as well as several privately ... Her experiences range from benefit plan design, vendor management, ...
(Date:3/1/2015)... March 01, 2015 Theme and plugin ... transition pack for Final Cut Pro X ... style transitions to any FCPX editors project.” Said Christiana ... users the tools needed to easily drag and drop ... user gets many different controls over the parameters of ...
Breaking Medicine News(10 mins):Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2
... to a new study, lack of sleep in children, ... the University of Laval's faculty of medicine studied 422 ... the weight, height, and waist size of each participant. ... lifestyle and socio-economic status through phone interviews with their ...
... finding about latest treatments available and practical cancer advice ... cancer study. Clive Seale, a sociology professor, has conducted ... to gender. The findings of the present study can ... help cancer patients. ,Questions were raised among ...
... Public Health Ministry of Afghanistan said on Sunday, that they ... called "Health for All and Health by All", is being ... conference being held in Afghanistan over the past four years. ... meeting to discuss the need for mutual cooperation to curb ...
... Marine Resources has dismissed the possibility of bird flu outbreak ... of chickens in the Bondoukou region were not due to ... of the death is still unknown. It has however been ... the chickens were negative for the bird flu virus. The ...
... go to hospitals with injuiries due to falls most of ... Medical// Journal of Australia. ,38 per cent or ... hospital cases. ,Associate Professor David Fonda, director of ... and incorporated a falls prevention program into the aged ...
... they will live longer than their ancestors, but do not ... available// for long-term care. ,“We spend more ... than we do when selecting a nursing home or assisted ... A&M Health Science Center School of Rural Public Health and ...
Cached Medicine News:Health News:Gender Difference In Reaction To Cancer 2Health News:Afghanistan Hosting A UN Funded Regional Health Conference 2
Achieving Topical Hemostasis After Catheterization Does Not Have to Be Complicated or Costly. Clo-Sur P.A.D. is intended for topical use in the local management of bleeding wounds, such as vascular ...
Provides the security of suture and ease of automated knot tying for vascular closure of 5-8F....
... corrected with GP lenses. Even though good ... lenses will help the patient adapt to ... distortions of the corneal surface and provide ... challenge for even the most experienced practitioner. ...
... (MPM) devices allow physicians to successfully manage ... Aerotels MPM equipment, patients can sit in ... physicians conduct routine and comprehensive medical monitoring ... system, data is automatically recorded and transferred ...
Medicine Products: